MedPath

Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults

Not Applicable
Completed
Conditions
Glucose Intolerance
Interventions
Other: High Intensity Interval Training #1
Other: High Intensity Interval Training #2
Other: Moderate intensity continuous training
Other: High Intensity Interval Training #3
Registration Number
NCT02706093
Lead Sponsor
University of Michigan
Brief Summary

The overall objectives are to:

1. Assess mechanisms underlying HIIT-induced improvements in insulin resistance at the whole-body, tissue, and cellular levels.

2. Systematically compare different HIIT regimens to help identify effective "doses" of HIIT that may be optimal for improving metabolic health in obese adults.

3. Assess the ability/willingness of obese subjects to adhere to a long-term HIIT program.

Findings from these studies will greatly expand knowledge about the effects of HIIT on metabolic health, and will provide valuable information for development of programs aimed at maximizing key metabolic benefits of exercise.

Detailed Description

If subjects are eligible for the study, they will be randomized into one of four different exercise training groups. Before training (and twice after 3 months of training) subjects will participate in a "clinical study" in which they will be required to stay overnight in the hospital. During the clinical study, the research team will perform a series of metabolic tests. Before and after the 3 months of training, the research team will assess subjects "free-living" 24h blood sugar control using a Continuous Glucose Monitor (CGM). The research team will measure several other relevant clinical markers (e.g., whole body and regional body fat assessments \[Dual Energy X-ray Absorptiometry (DEXA) and Magnetic Resonance Imager (MRI)\], hepatic lipid accumulation \[MRI analysis\], blood lipid profile, resting metabolic rate, glycated hemoglobin \[hemoglobin A1c\]). After the first 3 months of training, adherence to the subjects assigned training program will be tracked for the next 9 months (1 year of training in total). One year after initiating a training program, subjects will be asked to return to the clinic for a quick follow-up visit where the research team will complete some standard clinical assessments (e.g., body weight, body composition, blood pressure, and a blood sample).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
129
Inclusion Criteria
  • Age: 18-40
  • Body Mass Index: 30-40 kg/m2
  • Waist circumference: 88-98cm for women and 100-110cm for men
  • Glucose intolerant (i.e., 2h glucose concentration during a screening oral glucose tolerance test (OGTT)= 140-199mg/dl
  • No regularly planned exercise/physical activity
  • Women must have regularly occurring menses and must be premenopausal
Read More
Exclusion Criteria
  • EKG abnormalities as assessed by the cardiologist on the research team
  • Evidence/history of cardiovascular or metabolic disease
  • Medications known to affect lipid or glucose metabolism
  • Pregnant or lactating
  • Tobacco or e-cigarette use
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High Intensity Interval Training #1High Intensity Interval Training #1Obese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.
High Intensity Interval Training #2High Intensity Interval Training #2Obese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.
Moderate intensity continuous trainingModerate intensity continuous trainingObese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.
High Intensity Interval Training #3High Intensity Interval Training #3Obese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.
Primary Outcome Measures
NameTimeMethod
Insulin SensitivityChange from Baseline at 3 months

A hyperinsulinemic-euglycemic clamp will be used to assess peripheral insulin sensitivity

Secondary Outcome Measures
NameTimeMethod
Continuous Glucose MonitoringChange from Baseline at 3 months
Adipose Tissue BiopsyChange from Baseline at 3 months

To measure cytokines

Muscle BiopsyChange from Baseline at 3 months

To measure Mitochondrial Proteins

Resting Metabolic Ratebaseline and 3 months

Trial Locations

Locations (1)

Suzette Howton

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath